Event
HAL study on neuroplasticity and therapeutic benefit is published in an international medical journal
Key points
- CYBERDYNE announced that HAL was identified in a systematic review as the only exoskeleton device inducing neuroplasticity while providing broad therapeutic benefits across spinal cord injury outcomes.
- The review was published in the June 2025 issue of Global Spine Journal and analyzed 27 clinical studies covering 591 spinal cord injury patients.
- CYBERDYNE tied the findings to HAL''s interactive biofeedback approach, which uses real-time bioelectrical signals to support voluntary movement.
Company context
CYBERDYNE is a Japanese wearable robotics company built around its Cybernics platform, with HAL as its core product family. The company develops and commercializes wearable robotic systems for neuromotor rehabilitation, movement support, and labor assistance, alongside related treatment and wellbeing services.
Context
- Company
- CYBERDYNE
- Segment
- Healthcare
- Event type
- Research Publication
- Geography
- Tsukuba · Japan